| 中文名稱:妥洛帕泛 | 英文名稱:Tulopafant |
| CAS:116289-53-3 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.38% | 產(chǎn)品類別: 抑制劑 |
| 貨號: T17178 |
| 名稱 | Tulopafant |
| 描述 | Tulopafant (RP 59227) is a potent platelet-activating factor (PAF) antagonist that increases capillary patency and prolongs allograft heart survival. |
| 體外活性 | Preincubation of neutrophils with Tulopafant (RP 59227) results in a concentration-dependent decrease in chemiluminescence produced by PAF-primed cells[2]. |
| 體內(nèi)活性 | Tulopafant (RP 59227) effectively reduces myocardial infarct size and decreases the incidence of ischemia and reperfusion-induced arrhythmias in barbital-anesthetized dogs[1]. Histological examination reveals a marked reduction in both interstitial hemorrhage and the deposition of platelets and granulocytes in capillaries of cardiac xenografts when recipient animals are pretreated with Tulopafant[1]. |
| 存儲條件 | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 關(guān)鍵字 | Tulopafant | RP-59227 | RP59227 | PAFR |
| 相關(guān)產(chǎn)品 | 48740 RP | Rupatadine Fumarate | Rupatadine | Cedrol | SDZ-62-434 | Ginkgolide B | PAF C-18 | Dersalazine | (Rac)-Modipafant | CP 96021 | 2-Acetylbenzoic acid | Rocepafant |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP7年
|
武漢鼎信通藥業(yè)有限公司
|
2026-07-24 | |
| 詢價 |
VIP6年
|
武漢鼎信通藥業(yè)有限公司
|
2026-07-24 | |
| ¥3500 |
VIP6年
|
武漢維斯爾曼生物工程有限公司
|
2026-07-24 |